Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia, Italy.
Drug Deliv. 2011 Jan;18(1):26-37. doi: 10.3109/10717544.2010.509362. Epub 2010 Aug 21.
Polysaccharide microparticles for the oral administration of gentamicin were designed in order to obtain an increased drug absorption by means of microparticle transport across the intestinal epithelia. Alginate/chitosan microparticles with a size of ~2 μm were developed by spray-drying a water solution containing the drug complexed with the polyanionic alginate and subsequent alginate cross-linking process by calcium ions and chitosan. The pre-formulation study, performed by changing the concentration of both cross-linkers, led to the selection of the most suitable formulation which was assayed for its capacity to be translocated across intestinal epithelia, via both M cells contained in Follicle Associated Epithelium (FAE) of Peyer's patches and enterocytes of the mucosal epithelium. An ex vivo perfusion technique of rabbit and rat intestinal tissues containing Peyer's patches combined with an in vitro method by using Caco-2 cell monolayers demonstrated the microparticulate carrier ability to be taken up by both M cells and enterocytes. However, only the endocytosis by M cells appeared to provide the microparticle transport from the epithelium toward deeper sub-epithelial regions.
为了通过微粒体运输穿过肠上皮来增加药物吸收,设计了用于庆大霉素口服给药的多糖微粒体。通过喷雾干燥含有与聚阴离子海藻酸钠复合的药物的水溶液,并随后通过钙离子和壳聚糖进行海藻酸钠交联过程,开发出粒径约为 2μm 的海藻酸钠/壳聚糖微粒体。通过改变两种交联剂的浓度进行预配方研究,导致选择最合适的配方,以评估其穿过肠上皮的迁移能力,通过派尔集合淋巴结的滤泡相关上皮(FAE)中的 M 细胞和粘膜上皮的肠细胞。含有派尔集合淋巴结的兔和大鼠肠组织的体外灌注技术与使用 Caco-2 细胞单层的体外方法相结合,证明了微粒载体能够被 M 细胞和肠细胞摄取。然而,只有 M 细胞的内吞作用似乎提供了从上皮到更深的上皮下区域的微粒体运输。